CTCarlos Alejandro Toro

Carlos Alejandro Toro

*This is an algorithmically generated author record based on publicly available information.

Carlos Alejandro Toro has a total of 191 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • VPS13A Disease (Chorea‐Acanthocytosis) in Puerto Rico; New Genetic and Clinical Observations

    by Cristal Alicea‐Malave, Antonio Velayos‐Baeza, Sylvette Ayala‐Peña, Laura Surillo‐Dahdah, Carmen Serrano, Matthew J. Barrett, Sara E. Berman, Alessandro Di Rocco, Kevin M. Flanigan, Zachary B. Jordan, et al.

    Background: VPS13A disease is a very rare neurodegenerative disorder caused by mutations in the VPS13A gene. Its prevalence appears to be relatively high in Puerto Ricans, although limited genetic information has been available. Objectives: To describe the genetics of VPS13A disease (chorea‐acanthocytosis) in Puerto Rico. Methods: Data were obtained from Puerto Rican patients with genetically confirmed VPS13A disease. Results: Eighteen cases were identified, all carrying at least one of four mutations, c.1400_1401del, c.3556_3557dup, c.3889C>T, and c.2825‐253_2905‐374del (exon_27‐deletion); six additional single variants were detected. Seizures were the presenting symptom in 53% of patients. Conclusion: The presence of these probable founder mutations could explain the apparently increased prevalence in Puerto Rico; half of the described variants are newly described mutations and half have been previously reported. Enhanced clinical awareness of the spectrum of presenting symptoms and diagnostic clues, and improved access to genetic testing are essential for timely diagnosis in this population.

  • Open Access

    Epidural Thin Film Implants of Polymerized Curcumin Downregulate Inflammatory Markers and Improve Functional Recovery After Spinal Cord Injury in Mice

    by Carlos A Toro, Nicholas P Johnson, Zaraa Suhail, Ruiwen Chen, John T. Leman, Nikita Waskiewicz, Shahrukh Khalique, Granit Oroshi, Gomathi Jayaraman, Alexey Kozlenkov, et al.

    We demonstrate for the first time that the natural antioxidant curcumin, when copolymerized with PEG and sebacoyl chloride, results in biomaterials that are solution processable into free-standing, epidurally implantable thin films, in mice with spinal cord injury (SCI). We show that these novel products can be epidurally implanted at the lesion site following incomplete contusive spinal cord injury in mice. In the polymeric form, these materials quench reactive oxygen species on-contact and retain their activity for vastly extended timescales relative to the curcumin small molecule itself, which is potent but short lived. The epidural thin film biomaterial implant resulted in a statistically significant improvement in functional recovery after SCI. Mechanistically, myelin staining revealed that the polymerized curcumin materials greatly enhanced white matter sparing. Immunohistochemical analysis also showed that expression of GFAP and Ib1a are significantly downregulated 200 µm rostral (but not caudal) to the injury site. Finally, bulk RNA sequencing analysis showed greatly reduced activation of pro-inflammatory gene expression program. The primary conclusion from these experiments is that polymerized curcumin epidural thin films effectively improve outcomes following SCI. The benefits of these novel biomaterials are demonstrated in vivo , for the first time, and suggest that poly(pro-drug) thin film implants may provide safe chronic, local delivery of active drugs following SCI for extended timescales.


  • Open Access

    Correction: Muscle-restricted knockout of connexin 43 and connexin 45 accelerates and improves locomotor recovery after contusion spinal cord injury

    by Carlos A. Toro, Rita De Gasperi, Katherine Vanselow, Lauren Harlow, Kaitlin Johnson, Abdurrahman Aslan, William A. Bauman, Christopher P. Cardozo, Zachary A. Graham

    A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval.• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used.The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.

  • Open Access

    Oral Administration of Boldine Reduces Spare Nerve Injury-Induced Neuropathic Pain

    by Jiangping Pan, Carlos A. Toro, Christine Chow, Yorley Duarte, Juan C. Sáez, Christopher P. Cardozo, Wei Zhao

    Background: Chronic pain is present in about 20% of the population and is a major burden to the health care system. About 30-40% of these patients report neuropathic pain. Neuropathic pain is defined as pain caused by injury or disease of the somatosensory nervous system. Current available treatments for neuropathic pain have limited efficacy and substantial side effects. Methods: To address the need for more effective and safer treatments for neuropathic pain, this study aimed to test whether boldine, a naturally occurring alkaloid, could attenuate neuropathic pain in a murine model of spared nerve injury (SNI). Von Frey filament test, hot/cold plate test and dynamic weight bearing test were used to assess pain phenotypes following SNI. Results: We found that boldine inhibited the lipopolysaccharide-induced overexpression of inflammatory markers in BV-2 microglial cells. Oral administration of boldine at 50 mg/kg body weight/day resulted in significant reduction of SNI-induced mechanical and thermal hypersensitivity. Boldine also corrected SNI-induced weight bearing deficits, which are an indication of spontaneous pain. Boldine significantly inhibited SNI-induced peripheral inflammation as indicated by reduced levels of inflammatory cytokines/chemokines in the serum. Immunofluorescence studies revealed that boldine reduced the number of reactive astrocytes and inhibited microglia activation in lumbar spinal cord. Conclusion: Our findings suggest that boldine may be a promising therapeutic candidate for the treatment of neuropathic pain, possibly through inhibition of glia activation and neuroinflammation.


  • Open Access

    Muscle-restricted knockout of connexin 43 and connexin 45 accelerates and improves locomotor recovery after contusion spinal cord injury

    by Carlos A. Toro, Rita De Gasperi, Katherine Vanselow, Lauren Harlow, Kaitlin Johnson, Abdurrahman Aslan, William A. Bauman, Christopher P. Cardozo, Zachary A. Graham

    Traumatic spinal cord injury (SCI) results in the disruption of physiological systems below the level of the spinal lesion. Connexin hemichannels (CxHCs) are membrane-bound, non-selective pore proteins that are lost in mature myofibers but reappear de novo on the sarcolemma after peripheral denervation, chronic SCI, diabetes, and severe systemic stress such as sepsis. Cx43 and Cx45 have been implicated as the major CxHCs present in diseased muscle, and muscle-restricted knockout of these genes reduces muscle atrophy after denervation, likely by reducing excess calcium influx with resultant inflammasome activation. A muscle-restricted Cx43/45 conditional knockout (mKO) mouse model was developed and tested to check whether it would improve outcomes following either a complete spinal cord transection at the level of thoracic vertebrae-9 (T9) or a motor-incomplete T9 impact-contusion SCI. mKO had no effect on the body mass after complete T9 transection. There was reduced atrophy of the plantaris 15 days post-SCI that was not associated with molecular markers of inflammation, hypertrophic/atrophic protein signaling, or protein and mRNA expression related to mitochondrial integrity and function. mKO mice had faster and greater locomotor recovery across 28 days after a motor-incomplete contusion SCI with no differences in spared white matter; male mKO mice generally had greater muscle mass than genotype controls post-injury, but muscle sparing was not observed in female mKO mice post-injury. The data establish a new paradigm where muscle Cx43/45 may contribute to the tissue crosstalk that determines the neuromuscular function of sub-lesional musculature after motor-incomplete SCI in a sex-dependent manner. Our novel findings should promote investigation to develop innovative treatment strategies to improve the function and quality of life for persons with SCI.


  • Pathophysiological role of connexin and pannexin hemichannels in neuromuscular disorders

    by Walter Vásquez, Carlos A. Toro, Christopher P. Cardozo, Luis A. Cea, Juan C. Sáez

    A growing body of research has provided evidence that de novo expression of connexin hemichannels and upregulation of pannexin hemichannels (Cx HCs and Panx HCs, respectively) in the cytoplasmic membrane of skeletal muscle (sarcolemma) are critical steps in the pathogenesis of muscle dysfunction of many genetic and acquired muscle diseases. This review provides an overview of the current understanding of the molecular mechanisms regulating the expression of Cx and Panx HCs in skeletal muscle, as well as their roles in both muscle physiology and pathologies. Additionally, it addresses existing gaps in knowledge and outlines future challenges in the field. image


  • Open Access

    Septin 7 interacts with Numb to preserve sarcomere structural organization and muscle contractile function

    by Rita De Gasperi, Laszlo Csernoch, Beatrix Dienes, Monika Gonczi, Jayanta K Chakrabarty, Shahar Goeta, Abdurrahman Aslan, Carlos A Toro, David Karasik, Lewis M Brown, et al.

    Here, we investigated the mechanisms by which aging-related reductions of the levels of Numb in skeletal muscle fibers contribute to loss of muscle strength and power, two critical features of sarcopenia. Numb is an adaptor protein best known for its critical roles in development, including asymmetric cell division, cell-type specification, and termination of intracellular signaling. Numb expression is reduced in old humans and mice. We previously showed that, in mouse skeletal muscle fibers, Numb is localized to sarcomeres where it is concentrated near triads; conditional inactivation of Numb and a closely related protein Numb-like (Numbl) in mouse myofibers caused weakness, disorganization of sarcomeres, and smaller mitochondria with impaired function. Here, we found that a single knockout of Numb in myofibers causes reduction in tetanic force comparable to a double Numb, Numbl knockout. We found by proteomics analysis of protein complexes isolated from C2C12 myotubes by immunoprecipitation using antibodies against Numb that Septin 7 is a potential Numb-binding partner. Septin 7 is a member of the family of GTP-binding proteins that organize into filaments, sheets, and rings, and is considered part of the cytoskeleton. Immunofluorescence evaluation revealed a partial overlap of staining for Numb and Septin 7 in myofibers. Conditional, inducible knockouts of Numb led to disorganization of Septin 7 staining in myofibers. These findings indicate that Septin 7 is a Numb-binding partner and suggest that interactions between Numb and Septin 7 are critical for structural organization of the sarcomere and muscle contractile function.

  • Open Access

    Septin 7 Interacts With Numb To Preserve Sarcomere Structural Organization And Muscle Contractile Function

    by Rita De Gasperi, Laszlo Csernoch, Beatrix Dienes, Monika Gonczi, Jayanta K. Chakrabarty, Shahar Goeta, Abdurrahman Aslan, Carlos A. Toro, David Karasik, Lewis M. Brown, et al.

    Here, we investigated mechanisms by which aging-related reductions of the levels of Numb in skeletal muscle fibers contribute to loss of muscle strength and power, two critical features of sarcopenia. Numb is an adaptor protein best known for its critical roles in development including asymmetric cell division, cell-type specification and termination of intracellular signaling. Numb expression is reduced in old humans and mice. We previously showed that, in mouse skeletal muscle fibers, Numb is localized to sarcomeres where it is concentrated near triads; conditional inactivation of Numb and a closely related protein Numb-like (NumbL) in mouse myofibers caused weakness, disorganization of sarcomeres and smaller mitochondria with impaired function. Here, we found that a single knockout of Numb in myofibers causes reduction in tetanic force comparable to a double Numb, NumbL knockout. We found by proteomics analysis of protein complexes isolated from C2C12 myotubes by immunoprecipitation using antibodies against Numb, that Septin 7 is a potential Numb binding partner. Septin 7 is a member of the family of GTP-binding proteins that organize into filaments, sheets and rings, and is considered part of the cytoskeleton. Immunofluorescence evaluation revealed a partial overlap of staining for Numb and Septin 7 in myofibers. Conditional, inducible knockouts of Numb led to disorganization of Septin 7 staining in myofibers. These findings indicate that Septin 7 is a Numb binding partner and suggest that interactions between Numb and Septin 7 are critical for structural organization of the sarcomere and muscle contractile function.

  • Open Access

    Boldine Alters Serum Lipidomic Signatures after Acute Spinal Cord Transection in Male Mice

    by Zachary A. Graham, Jacob A. Siedlik, Carlos A. Toro, Lauren Harlow, Christopher P. Cardozo

    Traumatic spinal cord injury (SCI) results in wide-ranging cellular and systemic dysfunction in the acute and chronic time frames after the injury. Chronic SCI has well-described secondary medical consequences while acute SCI has unique metabolic challenges as a result of physical trauma, in-patient recovery and other post-operative outcomes. Here, we used high resolution mass spectrometry approaches to describe the circulating lipidomic and metabolomic signatures using blood serum from mice 7 d after a complete SCI. Additionally, we probed whether the aporphine alkaloid, boldine, was able to prevent SCI-induced changes observed using these ‘omics platforms’. We found that SCI resulted in large-scale changes to the circulating lipidome but minimal changes in the metabolome, with boldine able to reverse or attenuate SCI-induced changes in the abundance of 50 lipids. Multiomic integration using xMWAS demonstrated unique network structures and community memberships across the groups.


  • Open Access

    Muscle-restricted Nox4 knockout partially corrects muscle contractility following spinal cord injury in mice

    by Carlos A. Toro, Rita De Gasperi, Abdurrahman Aslan, Nicholas Johnson, Mustafa M. Siddiq, Christine Chow, Wei Zhao, Lauren Harlow, Zachary Aaron Graham, Xin-Hua Liu, et al.

    Spinal cord injury (SCI) results in severe atrophy of skeletal muscle in paralyzed regions, and a decrease in the force generated by muscle per unit of cross-sectional area. Oxidation of skeletal muscle ryanodine 1 receptors (RyR1) reduces contractile force due to reduced binding of calstabin 1 to RyR1 together with altered gating of RyR1. One cause of RyR1 oxidation is NADPH oxidase 4 (Nox4). We have previously shown that in rats, RyR1 was oxidized and bound less calstabin 1 at 56 days after spinal cord injury (SCI) by transection. Here, we used a conditional knock-out mouse model of Nox4 in muscle to investigate the role of Nox4 in reduced muscle specific force after SCI. Peak twitch force in control mice after SCI was reduced by 42% compared to sham-operated controls but was increased by approximately 43% in SCI Nox4 conditional KO mice compared to SCI controls although it remained less than that for sham-operated controls. Unlike what observed in rats, after SCI the expression of Nox4 was not increased in gastrocnemius muscle and binding of calstabin 1 to RyR1 was not reduced in this muscle. The results suggest a link between Nox4 expression in muscle tissue and reduction in muscle twitch force, however further studies are needed to understand the mechanistic basis for this linkage.